Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Impact and cost-effectiveness of novel tuberculosis prevention strategies for migrants to Canada
FY 2024-25
Summary
Eliminating tuberculosis (TB) is a global priority. In Canada, rates have not changed in the past 20 years, with 5 people developing TB disease per 100,000 population per year. The burden of disease is especially high among people born abroad, who account for 75% of persons with TB disease in Canada, despite making up just 25% of the population. One in 4 people who migrate to Canada has dormant TB infection, which can progress to active disease. Preventive treatment exists, but providing it to everyone would be prohibitively expensive; hence, targeting those at highest risk for TB disease is vital.The World Health Organization has emphasized the role of new technologies. A promising new TB vaccine is currently undergoing a large-scale clinical trial. There are also new tests emerging to better predict which people with dormant TB infection will later develop TB disease. Finally, TB transmission can be reduced by actively finding and treating people with early TB disease;rather than waiting for them to become ill enough to seek medical attention.This project aims to evaluate the impacts of investment in these strategies in countries where TB is common, with respect to subsequent TB rates and related costs among migrants to Canada. Our lab has created a computer model that effectively simulates the epidemiology of TB in Canada; we will examine the effects of changes in the number of migrants with TB infection and active TB disease that result from these strategies. We will compare predicted TB cases, health impacts, and costs to help inform an optimal approach.No study has yet examined the effect of these advances on TB-related outcomes in Canada. This work will provide important guidance in ensuring that limited resources are used effectively, to help eliminate TB.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530278
Name
Harvey Kate
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Impact and cost-effectiveness of novel tuberculosis prevention strategies for migrants to Canada
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cost Analysis; Cost-Effectiveness; Decision Analysis; Global Health; Infectious Disease Modelling; Tuberculosis
Abstract
Eliminating tuberculosis (TB) is a global priority. In Canada, rates have not changed in the past 20 years, with 5 people developing TB disease per 100,000 population per year. The burden of disease is especially high among people born abroad, who account for 75% of persons with TB disease in Canada, despite making up just 25% of the population. One in 4 people who migrate to Canada has dormant TB infection, which can progress to active disease. Preventive treatment exists, but providing it to everyone would be prohibitively expensive; hence, targeting those at highest risk for TB disease is vital.The World Health Organization has emphasized the role of new technologies. A promising new TB vaccine is currently undergoing a large-scale clinical trial. There are also new tests emerging to better predict which people with dormant TB infection will later develop TB disease. Finally, TB transmission can be reduced by actively finding and treating people with early TB disease;rather than waiting for them to become ill enough to seek medical attention.This project aims to evaluate the impacts of investment in these strategies in countries where TB is common, with respect to subsequent TB rates and related costs among migrants to Canada. Our lab has created a computer model that effectively simulates the epidemiology of TB in Canada; we will examine the effects of changes in the number of migrants with TB infection and active TB disease that result from these strategies. We will compare predicted TB cases, health impacts, and costs to help inform an optimal approach.No study has yet examined the effect of these advances on TB-related outcomes in Canada. This work will provide important guidance in ensuring that limited resources are used effectively, to help eliminate TB.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Harvey, Kate
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~